- Home
- DDD vs RCKT Comparison
DDD vs RCKT Comparison
Compare DDD & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DDD | RCKT |
|---|---|---|
| Founded | 1986 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 373.9M | 428.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DDD | RCKT |
|---|---|---|
| Price | $2.77 | $3.62 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $4.75 | ★ $29.12 |
| AVG Volume (30 Days) | ★ 4.6M | 1.9M |
| Earning Date | 11-04-2025 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $391,651,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.31 | N/A |
| P/E Ratio | $25.21 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.32 | $2.19 |
| 52 Week High | $5.00 | $11.45 |
Technical Indicators
Market Signals| Indicator | DDD | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 69.12 | 52.67 |
| Support Level | $2.26 | $3.47 |
| Resistance Level | $2.72 | $3.98 |
| Average True Range (ATR) | 0.21 | 0.23 |
| MACD | 0.09 | 0.01 |
| Stochastic Oscillator | 96.26 | 43.48 |
Price Performance
Historical ComparisonAbout DDD 3D Systems Corporation
3D Systems Corp provides comprehensive 3D printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The company's segments include Healthcare Solutions and Industrial Solutions. It generates maximum revenue from the Industrial segment. It conducts business through various offices and facilities located throughout the Americas, EMEA, and APAC; generating a vast majority of revenues from the Americas.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.